The existence of a putative post-transcriptional regulatory element in 3′-UTR of drosophila antibacterial peptide diptericin’s mRNA  by Chen, Hai-xu et al.
The existence of a putative post-transcriptional regulatory element in
3P-UTR of drosophila antibacterial peptide diptericin’s mRNA
Hai-xu Chena;b, Yue Lia;b, Zhao-zhao Jianga, Xian-ming Qub, Sheng-li Yangb, Wei-jun Maa;b;
aHealth Science Center, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and Shanghai Second Medical University,
225 South Chongqing Road, Shanghai 200025, PR China
bShanghai Research Center of Biotechnology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 500 Caobao Road,
Shanghai 200233, PR China
Received 6 October 2003; revised 11 December 2003; accepted 13 January 2004
First published online 23 February 2004
Edited by Pascale Cossart
Abstract Antibacterial peptides’ genes are rapidly and transi-
ently expressed on immune stimulation, which is the character-
istic of immediate early genes. It implies post-transcriptional
regulation is an important pathway in antibacterial peptides’
gene expression. In a search of putative post-transcriptional
regulatory elements, we found a segment of an AU-rich se-
quence in 3P-untranslated region (UTR) of drosophila diptericin
mRNA. 3P-UTR of diptericin mRNA can be speci¢cally bound
with Elav and this binding can be competed with the typical AU-
rich element (ARE) of c-fos mRNA. These results suggest that
the AU-rich sequence in the 3P-UTR of diptericin mRNA may
be a cis-acting element and involved in post-transcriptional reg-
ulation.
' 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Insects possess an e⁄cient immunity system against patho-
gens [1]. The induced synthesis of antibacterial peptides plays
an important role in this system [2]. Antibacterial peptides’
genes are rapidly and transiently expressed [3]. Some of the
transcriptional regulatory mechanisms involved in induced ex-
pression of these genes are relatively well understood [4^6]
and similar at a molecular level to those in mammalian acute
phase responses [7]. The rapidity and transiency of antibacte-
rial peptides’ gene expression are the characteristics of imme-
diate early genes [8], and many immediate early mRNAs are
targeted for post-transcriptional regulation by virtue of cis-
acting elements in their 3P-untranslated region (UTR) [9^13].
So this suggests that the post-transcriptional regulation may
be an important pathway in the antibacterial peptides’ gene
expression.
Diptericins are inducible 9-kDa antibacterial peptides and
the drosophila diptericin gene is strongly expressed 1^2 h after
bacterial challenge [14,15]. Two decameric nuclear factor
(NF)-UB-related sequences [16] and motifs similar to interfer-
on-sensitive response elements from mammalian genes [17^19]
are located upstream of the TATA-box in the diptericin pro-
moter. In addition to transcriptional regulation, post-tran-
scriptional regulation may contribute to the diptericin gene
expression. However, no report on characterization of dipter-
icin cis-acting elements involved in post-transcriptional regu-
lation is present. In a search of putative cis-acting elements in
drosophila antibacterial peptides’ mRNA, we found a seg-
ment of an AU-rich sequence in 3P-UTR of diptericin
mRNA, which is similar with AU-rich elements (AREs).
AREs are typical cis-acting elements that have been identi¢ed
in many mRNAs [20^23]. We anticipate that this AU-rich
segment in diptericin mRNA may be a cis-acting element.
In order to characterize this element, RNA binding protein
Elav from drosophila [24] was used for RNA^protein inter-
action analysis, since Elav-like proteins can bind to ARE with
high a⁄nity and selectivity [25^28]. The biological relevance
of these interactions has come to light when in vivo studies
showed that HuR, a member of Elav-like proteins, partici-
pates in stabilization of the VEGF transcript [29].
2. Materials and methods
2.1. Cloning and construction of diptericin in vitro transcription
plasmids
Total RNA was extracted from the wild-type Berlin £ies using
Trizol (Gibco BRL) and reverse transcribed with oligo(dT)18 primer.
The following oligodeoxynucleotides were then used to amplify the
diptericin gene: P_dptF, 5P-GGGAATTCGAGAACAACTGAGAT-
GC-3P and P_dptR, 5P-CTGGATCCGCTAGACTCGGATACC-3P.
The following oligodeoxynucleotides were used to amplify the dipter-
icin coding sequence with 5P-UTR: P_dptF and P_dpt-codR, 5P-
GCGGATCCTTCGGAAATCTGTAGG-3P. The following oligo-
deoxynucleotides were used to amplify diptericin 3P-UTR: P_dpt-
3utrF, 5P-CTGAATTCCACCTACAGATTTCCGA-3P and P_dptR.
All polymerase chain reaction (PCR) products were digested with
BamHI/EcoRI and subcloned into BamHI/EcoRI-digested pGEM-
3Z vector (Promega). The resultant plasmids were called pGEM-
dpt, pGEM-dpt_cod and pGEM-dpt_3utr, respectively.
In vitro transcription plasmid pGEM-dptvAU encoding the dip-
tericin gene minus the AU-rich segment (sequence from residue 3 to
27 downstream of the diptericin stop codon) was constructed as fol-
lows: pGEM-dpt was used as the template and the oligodeoxynucleo-
tides P_dpt-loss5, 5P-CTTCACCAAATATTATCTCGATTGG-3P and
P_dpt-loss3, 5P-GCTTAGAAATTCGGAAATCTGTAGGTGTATC-
C-3P were used as primers for PCR; the PCR product was phosphate
labeled using T4 kinase and ligated to itself using T4 DNA ligase.
2.2. Construction of a glutathione S-transferase (GST)-Elav fusion
protein plasmid
A cDNA encoding residues 2^483 of Elav was generated using PCR
with upstream primer P_elavF, 5P-GACCCGGGAATGGCCTTTAT-
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TATGGCAAATACCGG-3P and downstream primer P_elavR, 5P-
CTGAATTCCTACTTGGCTTTGTTGGTCTTGAAG-3P. The resul-
tant product was digested with SmaI/EcoRI and subcloned into SmaI/
EcoRI-digested pGEX-2T (Pharmacia). The resultant construct was
called pGEX-Elav.
2.3. Puri¢cation of GST-Elav protein
0.5 ml overnight culture of Escherichia coli BL21, transformed with
pGEX-Elav, was diluted in 50 ml Luria^Bertani (LB) medium and
incubated at 37‡C for 2 h. The culture was induced with isopropyl
thiogalactose (IPTG) (0.04 mM). After 4 h of further growth at 30‡C,
E. coli cells were spun down and suspended in 5 ml bu¡er A (50 mM
Tris (pH 8.0), 200 mM NaCl, 1 mM ethylenediamine tetraacetic acid
(EDTA)). The cells were lysed by adding lysozyme to a ¢nal concen-
tration of 0.2 mg/ml and Triton X-100 to 1%. The lysate was centri-
fuged at 12 000Ug for 30 min. The resultant supernatant was mixed
with 0.15 ml glutathione Sepharose 4B and incubated with gentle
agitation at room temperature for 1 h. The suspension was centri-
fuged at 1000Ug for 5 min. After washing the pellet three times
with 1.5 ml bu¡er A, the bound protein was eluted with elution bu¡er
(50 mM Tris (pH 8.0), 10 mM glutathione).
2.4. Preparation of RNA transcripts
Plasmids were digested with the appropriate restriction enzymes
and transcribed using MAXIscript kit (Ambion). For the synthesis
of biotin-labeled RNA, 50% ribocytidine triphosphate (rCTP) were
replaced by biotin-14-CTP (Invitrogen). pAUFL [30] was linearized
with HindIII and transcribed with T3 RNA polymerase, yielding a
transcript (called AUFL) of 251 nucleotides of 3P-UTR of c-fos
mRNA. pSP65HQ [26] was linearized with Sau3AI and transcribed
with SP6 RNA polymerase, yielding 165 nucleotides containing 80
nucleotides of the coding sequence and 85 nucleotides of 3P-UTR of
human Q-globin. pGEM-dpt was linearized with BamHI and tran-
scribed with T7 RNA polymerase, yielding a transcript of 391 nucleo-
tides of diptericin mRNA. pGEM-dpt_cod was linearized with Bam-
HI and transcribed with T7 RNA polymerase, yielding a transcript
(called dpt_cod) of 327 nucleotides containing 314 nucleotides of the
coding sequence and 13 nucleotides of 5P-UTR of diptericin mRNA.
pGEM-dpt_3utr was linearized with BamHI and transcribed with T7
RNA polymerase, yielding a transcript (called dpt_3utr) containing 57
nucleotides of 3P-UTR of diptericin mRNA. pGEM-dptvAU was
linearized with BamHI and transcribed with T7 RNA polymerase,
yielding a transcript of 366 nucleotides of diptericin mRNA minus
the AU-rich segment (called dptvAU).
A gene fragment (called dpt-mut) was ampli¢ed by PCR as follows:
P_T7, 5P-GTAATACGACTCACTATAGGG-3P and P_dpt-mut, 5P-
CGGATACC AATCGAGATAATATTTGGTGAAGTTTTTTACA-
ATGCGATATTTATGAAGC-3P were used as primers and pGEM-
dpt was used as the template. The ampli¢ed dpt-mut DNA fragment
was transcribed with T7 RNA polymerase, yielding a transcript of 391
nucleotides of the dpt-mut RNA.
2.5. Gel retardation assay
Reaction mixtures (0.02 ml) contained 50 mM Tris (pH 7.0), 150
mM NaCl, 0.25 mg/ml tRNA, 0.25 mg/ml bovine serum albumin,
RNA and protein as indicated. The mixture was incubated at 37‡C
for 10 min. Following incubation, 2 Wl of a dye mixture (50% glycerol,
0.025% bromophenol blue, 0.025% xylene cyanol) was added. The
reaction mixture was immediately loaded on a 1% agarose gel in
TBE bu¡er and electrophoresed at 70 V for 45 min.
2.6. Detection of the biotin-labeled RNA and quanti¢cation of its
optical density
The RNA was transferred from gel to nylon membrane Zeta-Probe
(Bio-Rad) using capillary transfer [31]. After being exposed to 302 nm
radiation on a ultraviolet (UV) transilluminator for 3 min, the mem-
brane was incubated in the block solution (0.1 M Tris, pH 7.5, 0.1 M
NaCl, 2 mM MgCl2, 3% bovine serum albumin fraction V) at 30‡C
for 1 h and then incubated at 30‡C with 0.85 Wg/ml alkaline phospha-
tase-linked streptavidin (Promega) in 10 ml AP7.5 bu¡er (0.1 M Tris
pH 7.5, 0.1 M NaCl, 2 mM MgCl2) for 10 min. After being washed
twice with AP7.5 bu¡er and once with AP9.5 bu¡er (0.1 M Tris pH
9.5, 0.1 M NaCl, 50 mM MgCl2), the membrane was incubated with
2.5 mg nitroblue tetrazolium (NBT) and 1.25 mg 5-bromo-4-chloro-3-
indolyl phosphate (BCIP) in 7.5 ml AP9.5 bu¡er at room temperature.
After 30 min, TE was added to stop the reaction.
After the color development reaction of biotin-labeled RNA, the
nylon membrane was scanned by a scanner. The optical density of
each band was quanti¢ed using ImageQuant version 5.2 software
(Molecular Dynamics). The integrated density of all the pixels in
the area of each band was quanti¢ed and adjusted by a background
subtraction of density in nested blank area of the same size. This
value represents the integrated optical density of the band.
3. Results
3.1. The diptericin mRNA can form RNA^protein complex
with Elav protein
In gel retardation assay, puri¢ed GST-Elav can convert the
diptericin mRNA to a stable RNA^protein complex that mi-
grates more slowly on agarose gel than diptericin mRNA
alone (Fig. 1, lane 1 vs. lane 2). The complex formation is
speci¢c, since no reaction was observed with 3P-UTR of Q-glo-
bin mRNA (Fig. 1, lane 3 vs. lane 4).
3.2. The diptericin mRNA can be bound with Elav protein in a
concentration-dependent pattern
The amount of the formed RNA^protein complex increased
when the concentration of GST-Elav increased from 25 to 800
nM (Fig. 2A, lanes 3^8). No complex formation was observed
with high concentrations (1000 nM) of puri¢ed GST (Fig. 2A,
lane 1 vs. lane 2). Thus Elav speci¢cally binds to the diptericin
mRNA.
In order to make quantitative analysis on the interaction
between diptericin mRNA and Elav, we need to estimate the
quantity of biotin-labeled diptericin mRNA on the nylon
membrane. We used a series of biotin-labeled diptericin
mRNA samples whose quantities are 2.42, 7.26, 21.8, 65.4
and 196 fmol and measured their corresponding optical den-
sities after electrophoresis. The optical density of biotin-la-
beled diptericin mRNA versus the logarithm of diptericin
mRNA quantity reveals a straight line within this range.
The diptericin mRNA quantity and optical densities measured
in all experiments lie in this linear range. With this standard
curve, the biotin-labeled diptericin mRNA quantity can be
Fig. 1. The binding of diptericin mRNA to Elav. 5 nM biotin-la-
beled diptericin mRNA or 5 nM Q-globin mRNA (3P-UTR) was in-
cubated with the indicated concentrations of Elav. Following incu-
bation at 37‡C for 10 min, the reaction mixture was resolved by gel
electrophoresis on a 1% agarose gel.
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calculated according to the optical density of biotin-labeled
diptericin mRNA within the linear range.
We employ this quantitative method to measure and ana-
lyze lanes 3^8 of Fig. 2A and calculate the quantities of the
unbound diptericin mRNA and bound diptericin mRNA (re-
tarded). The relationship between percentage of bound dipter-
icin mRNA and the concentration of Elav is shown in Fig.
2B, which is in accordance with S-shape binding curve. When
Elav is about 130 nM, 50% mRNA was converted into RNA^
protein complex. Thus the apparent dissociation constant (Kd)
of Elav^diptericin interaction is about 1.3U102 nM.
3.3. Diptericin mRNA binding to Elav can be competed by
AUFL RNA
We next determined whether the Elav^diptericin interaction
Fig. 2. The diptericin mRNA can be bound with Elav in a concen-
tration-dependent pattern. A: 5 nM biotin-labeled diptericin mRNA
was incubated with the indicated concentrations of GST or GST-
Elav. Following incubation at 37‡C for 10 min, the reaction mixture
was resolved by gel electrophoresis on a 1% agarose gel. B: Plot of
percentage of bound RNA versus Elav concentration.
Fig. 3. The Elav^diptericin complex is displaced by AUFL RNA.
5 nM biotin-labeled diptericin mRNA was incubated with 300 nM
Elav protein. The indicated unlabeled AUFL RNA or unlabeled Q-
globin mRNA (irrelevant RNA) was added into the reaction mix-
ture. After 10 min of incubation at 37‡C, the reaction mixture was
resolved on 1% agarose gel.
Fig. 4. Elav binds to the 3P-UTR of diptericin mRNA. A: The se-
quence of 3P-UTR of the diptericin mRNA. The segment of AU-
rich sequence is underlined. B: 5 nM biotin-labeled diptericin 5P-
UTR with coding sequence or 5 nM diptericin 3P-UTR was incuba-
ted with the indicated concentrations of Elav. Following incubation
at 37‡C for 10 min, the reaction mixture was resolved by gel elec-
trophoresis on a 1% agarose gel. C: 5 nM biotin-labeled diptericin
mRNA was incubated with 300 nM Elav protein. The indicated un-
labeled diptericin 3P-UTR RNA was added into the reaction mix-
ture. After 10 min of incubation at 37‡C, the reaction mixture was
resolved on 1% agarose gel.
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has similarity with the typical interaction between ARE and
Elav-like proteins. The competition experiment was carried
out to check whether diptericin mRNA would be displaced
by AUFL RNA for bound with Elav. As shown in Fig. 3,
from lanes 2 to 5, Elav^diptericin complex formation de-
creased when the AUFL RNA quantity increased. When 80
nM or more AUFL RNA was added, no Elav^diptericin for-
mation existed (Fig. 3, lanes 6, 7). Elav^diptericin complex
can be eliminated by AUFL RNA, and no inhibition was
observed when 160 nM Q-globin mRNA was added (Fig. 3,
lane 8). So AUFL RNA can e¡ectively compete with dipter-
icin mRNA for Elav binding; diptericin mRNA and ARE
may have similarity in the binding site or interaction pattern
with Elav.
3.4. Elav binds to the 3P-UTR of diptericin mRNA
We next located the Elav binding part on diptericin mRNA
in more detail. Two transcripts were synthesized: dpt_cod
which contained the coding sequence with 5P-UTR and
dpt_3utr which contained 3P-UTR of diptericin mRNA (se-
quence shown in Fig. 4A). Gel retardation reveals that Elav
binds to the 3P-UTR of diptericin mRNA (Fig. 4B, lanes 3, 4)
while no binding was observed with the coding sequence with
5P-UTR in the presence of 800 nM Elav (Fig. 4B, lanes 1, 2).
And as shown in Fig. 4C, diptericin 3P-UTR can e¡ectively
compete with diptericin mRNA for Elav binding.
3.5. Mutational analysis of AREs in 3P-UTR of diptericin
mRNA
Transcript dptvAU has a deletion of the AU-rich segment
(sequence from residues 3 to 27 downstream of the diptericin
stop codon), and transcript dpt-mut RNA di¡ers from dipter-
icin mRNA in the AU-rich region from residues 13 to 16
downstream of the diptericin stop codon: UCGC for dpt-
mut and UUUU for diptericin. Agarose gel retardation re-
vealed that no complex formation was observed with dptvAU
RNA (Fig. 5A, lane 1 vs. lane 2) or dpt-mut RNA (Fig. 5B,
lane 1 vs. lane 2) at 800 nM Elav.
3.6. Complex formation of diptericin mRNA with ARE binding
protein HuR
We next determined whether the diptericin mRNA could be
bound with HuR, an ARE binding protein. As shown in Fig.
6, the amount of the formed RNA^protein complex increased
when the concentration of GST-HuR increased from 25 to
800 nM (Fig. 6, lanes 3^8). No complex formation was ob-
served with high concentrations (1000 nM) of puri¢ed GST
(Fig. 6, lane 1 vs. lane 2). Thus the diptericin mRNA can be
bound with ARE binding protein HuR.
4. Discussion
In this paper, our results demonstrate that 3P-UTR of dip-
Fig. 5. Mutated 3P-UTR of diptericin mRNA could not bind to
Elav. A: 5 nM biotin-labeled dptvAU RNA was incubated with the
indicated concentrations of Elav. Following incubation at 37‡C for
10 min, the reaction mixture was resolved by gel electrophoresis on
a 1% agarose gel. B: 5 nM biotin-labeled dpt-mut RNA was incu-
bated with the indicated concentrations of Elav. Following incuba-
tion at 37‡C for 10 min, the reaction mixture was resolved by gel
electrophoresis on a 1% agarose gel.
Fig. 6. Complex formation of diptericin mRNA with Elav-like pro-
tein HuR. 5 nM biotin-labeled diptericin mRNA was incubated
with the indicated concentrations of GST or GST-HuR. Following
incubation at 37‡C for 10 min, the reaction mixture was resolved by
gel electrophoresis on a 1% agarose gel.
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tericin mRNA can be bound by Elav with speci¢city and this
binding can be e¡ectively competed by AUFL (3P-UTR of c-
fos mRNA). It suggests that 3P-UTR of the diptericin mRNA
contains a cis-acting element, which is very likely to play a
role in the post-transcriptional regulation. The post-transcrip-
tional regulation of the diptericin mRNA can be a very e¡ec-
tive molecular adaptation that enables the cell to maintain a
translatable transcript without embarking upon transcription
and respond rapidly to extrinsic or intrinsic immunity stimuli.
We found out the similarity between the Elav^diptericin
interaction and the Elav^AUFL interaction. The Elav^dipter-
icin interaction can be competed by AUFL. The ARE of
AUFL has been functionally de¢ned by deletion analysis.
Moreover, HuR [25], which specially binds to the ARE of
AUFL, can form RNA^protein complex with diptericin
mRNA. The apparent Kd of HuR with diptericin is about
210 nM which is comparable with but slightly higher than
that of Elav. Since HuR is an ARE binding protein from
human, it shows typical binding feature and capability to
ARE containing mRNA. According to these results, we an-
ticipated that Elav binds to ARE of the diptericin 3P-UTR.
It was reported that the AU-rich sequence in the 3P-UTR of
sarcotoxin II (a kind of antibacterial peptide from Sarcoph-
aga) mRNA can cause instability of mRNA [32] and a protein
that can bind to this sequence was puri¢ed from Sarcophaga
pupal extract. The molecular mass of this protein was esti-
mated to be 39 kDa. Moreover, this protein has thiolase ac-
tivity [33]. However, according to the data from this paper,
this RNA binding protein showed little binding speci¢city
with the AU-rich sequence; its a⁄nity with tRNA or other
RNA was similar to the AU-rich sequence. This protein is
‘broad spectrum’ regarding its ability of binding RNA. The
RNA^protein complex was observed in the absence of tRNA
as a non-speci¢c competitor. In our results we use an excess
amount of tRNA as non-speci¢c competitor to assure the
speci¢city of ARE^protein interaction. We assume that
Elav-like proteins and thiolase should be di¡erent in the spec-
i¢city and functionality of interacting with RNAs. They play
di¡erent roles in RNA^protein interaction.
Further study on the mode of Elav^diptericin interaction is
needed. The binding site of Elav within the diptericin 3P-UTR
will be further located, and mutations of the diptericin ARE
can be synthesized to check out the sequence motif required
for binding. Moreover, the diptericin ARE or its mutations
can be inserted downstream of the reporter gene to examine
the in£uence and e¡ectiveness on the post-transcriptional reg-
ulation of the reporter gene in vivo. These studies will help to
understand the critical structural features and function of the
ARE that may be involved in the ARE-directed diptericin
gene regulation at the post-transcriptional level, such as
RNA processing, translation and RNA degradation. Since
in vivo studies show that HuR, a human Elav-like protein,
regulates the stability of ARE containing mRNA [29], it is
likely that 3P-UTR regulatory element may a¡ect the dipter-
icin mRNA stability by interaction with Elav in the post-tran-
scriptional regulation.
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